GNC's New Partner Brings China Access And Funding, Takes Board Seats
This article was originally published in The Rose Sheet
Executive Summary
As GNC reports substantially trimming its net losses in its 2017 fourth-quarter and full-year results, it announces Harbin Pharmaceutical will invest around $300m in GNC, becoming the single largest shareholder, and the two firms will form a JV for manufacturing, marketing and distributing GNC-branded products in China. With the investment, GNC's board expands from six to 11 members, comprising GNC CEO Ken Martindale, five appointed by Harbin and five by GNC.
You may also be interested in...
Health, Beauty And Wellness News: Herbalife Q3, NPA On Part 111 Trends, AHPA's Zimmerman Awarded
AHPA's Zimmerman receives AHG's 'Best Contribution' award; NPA notes Part 111 violations common and emerging; saw palmetto BAPP update notes adulteration developments; China results lead Herbalife sales jump; and China deal delay moves GNC Q3 report date.
Health, Beauty And Wellness News: GNC, Herbalife, Natural Grocers, Welch's
GNC adds chairman to CEO Ken Martindale’s role, with previous chair Bob Moran staying as lead independent director; Herbalife reports 12% second-quarter growth; Natural Grocer by Vitamin Cottage net sales grow on increased daily transactions in both comparable and new stores; and Welch expands Welch's focused on men.
GNC Links Pipeline To Loyalty Program Trends, Builds Private Label Lines
CEO Ken Martindale says research and development linked to firm’s loyalty program, which provides data on the needs of the nearly 15m customers enrolled. “The data-driven insight we gain from our loyalty program are beginning to help us shape our product development and innovation,” he says.